NCT06764849

Brief Summary

This study aims to demonstrate that open excisional hemorrhoidectomy (OEH), when performed using a minimally invasive approach, results in less postoperative pain and comparable outcomes to conventional OEH.

Trial Health

45
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
6mo left

Started Feb 2026

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress51%
Feb 2026Feb 2027

First Submitted

Initial submission to the registry

December 23, 2024

Completed
16 days until next milestone

First Posted

Study publicly available on registry

January 8, 2025

Completed
1.1 years until next milestone

Study Start

First participant enrolled

February 1, 2026

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2027

Expected
Last Updated

September 3, 2025

Status Verified

August 1, 2025

Enrollment Period

Same day

First QC Date

December 23, 2024

Last Update Submit

August 26, 2025

Conditions

Keywords

hemorrhoidal diseaseminimally invasive open excisional hemorrhoidectomyopen excisional hemorrhoidectomy

Outcome Measures

Primary Outcomes (2)

  • Postoperative pain measured with the visual analogic scale

    Postoperative pain presented 10 days after the surgical procedure was measured using the visual analogic scale (VAS). Operationally, a VAS is a horizontal line 100 mm long anchored by word descriptors at each end; on the left-hand end, it says "no pain," and on the right-hand end of the line, it says "very severalPostoperative pain was assessed 10 days after the surgical procedure using the visual analog scale (VAS). The VAS consists of a 100 mm horizontal line, with descriptors at each end. The left end is labeled "no pain," while the right end is labeled "very severe pain." Patients indicate their perception of pain by marking a point on the line. The VAS score is then calculated by measuring the distance in millimeters from the left end of the line to pain". The patient marks on the line the point that they feel represents their perception of their current state. The VAS score is determined by measuring millimetres from the left-hand end of the line to the point the patient marks.

    10 days

  • Postoperative pain measured by the number of rescue painkillers needed

    Postoperative pain presented 10 days after the surgical procedure was measured with the number of rescue painkillers needed during this period. Patients will take the following analgesic regimen: Paracetamol 1 gram every 8 hours and Dexketoprofen 12.5 milligrams every 8 hours alternately. Tramadol 50 milligrams will be used as rescue analgesia. The patient will write down the number of Tramadol tablets needed during the first 10 days on a collection sheetPostoperative pain will be assessed 10 days after the surgical procedure by recording the number of rescue painkillers used during this time. Patients will follow this analgesic regimen: they will take Paracetamol 1 gram every 8 hours and Dexketoprofen 12.5 milligrams every 8 hours, alternating between the two. Tramadol 50 milligrams will be available as rescue analgesia. Patients should note the number of Tramadol tablets taken during the first 10 days on a collection sheet..

    10 days

Secondary Outcomes (2)

  • Efficacy of the treatment using the Hemorrhoidal Disease Symptom Score

    1 year

  • Efficacy of treatment using the Short Health Scale adapted for hemorrhoidal disease

    1 year

Study Arms (2)

OPEN EXCISIONAL HEMORRHOIDECTOMY

ACTIVE COMPARATOR

Patients will undergo conventional open excisional hemorrhoidectomy

Procedure: CONVENTIONAL OPEN EXCISIONAL HEMORRHOIDECTOMY

MINIMALLY INVASIVE OPEN EXCISIONAL HEMORRHOIDECTOMY

EXPERIMENTAL

Patients will undergo open excisional hemorrhoidectomy using a minimally invasive technique

Procedure: MINIMALLY INVASIVE OPEN EXCISIONAL HEMORRHOIDECTOMY

Interventions

Hemorrhoidectomy performed based on the conventional technique described by Milligan-Morgan

OPEN EXCISIONAL HEMORRHOIDECTOMY

Hemorrhoidectomy performed based on the tecnique described by Milligan Morgan, using a minimally invasive approach.

MINIMALLY INVASIVE OPEN EXCISIONAL HEMORRHOIDECTOMY

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age older than 18 years.
  • Hemorrhoids grade III.
  • Surgical indication for hemorrhoidal disease.

You may not qualify if:

  • Acute hemorrhoidal disease.
  • Previous hemorrhoidal surgery.
  • Concomitant anal fissure.
  • Concomitant anal fistulae.
  • Concomitant rectal prolapse.
  • Concomitant inflamatory bowel disease or anal cancer.
  • Language impairment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Rorvik HD, Styr K, Ilum L, McKinstry GL, Dragesund T, Campos AH, Brandstrup B, Olaison G. Hemorrhoidal Disease Symptom Score and Short Health ScaleHD: New Tools to Evaluate Symptoms and Health-Related Quality of Life in Hemorrhoidal Disease. Dis Colon Rectum. 2019 Mar;62(3):333-342. doi: 10.1097/DCR.0000000000001234.

    PMID: 30451751BACKGROUND

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
GENERAL SURGERY SPECIALIST

Study Record Dates

First Submitted

December 23, 2024

First Posted

January 8, 2025

Study Start

February 1, 2026

Primary Completion

February 1, 2026

Study Completion (Estimated)

February 1, 2027

Last Updated

September 3, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share